Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Lifecare ASA Board/Management Information 2023

Dec 19, 2023

3654_rns_2023-12-19_322f5ff3-2770-4be6-8032-232f556c9535.html

Board/Management Information

Open in viewer

Opens in your device viewer

LIFE: Prof. Dr. Tony James joining Lifecare's Scientific Advisory Board

LIFE: Prof. Dr. Tony James joining Lifecare's Scientific Advisory Board

Professor Dr. Tony James will join Lifecare's Scientific Advisory Board. - We

have collaborated with Professor Tony James since 2019, and we are really

excited to bring him on board in this position, says CEO Joacim Holter.

Tony James is professor of Chemistry at the University of Bath and Fellow of

the Royal Society of Chemistry. He has received the Daiwa-Adrian Prize for

developing scientific links with Japan, the CASE Prize for establishing

scientific networks with China, the MSMLG Czarnik Award, the Frontiers in

Chemistry Diversity Award and a Royal Society Wolfson Research Merit Award. He

is also listed by Clarivate as a Highly Cited Researcher in Chemistry.

-- Tony James has an outstanding academic record. He has published over 470

publications, including three books, 10 book chapters and 457 papers in

international peer reviewed journals. Professor James is also the named

inventor on 30 international patents and has delivered 266 invited lectures

within the UK and internationally. He is a remarkable asset for Lifecare,

Holter points out.

The CEO of Lifecare states that he is very pleased that Prof James will now

add valuable insight within his area of expertise to our highly competent

Scientific Advisory Board.

Lifecare's Scientific Advisory Board is chaired by the distinguished Prof.

David C. Klonoff: https://lifecare.no/about-lifecare/#scientificadv

About us

Lifecare AS is a clinical stage medical sensor company developing technology

for sensing and monitoring of various body analytes. Lifecare's main focus is

to bring the next generation of Continuous Glucose Monitoring ("CGM") systems

to market. Lifecare enables osmotic pressure as sensing principle, combined

with the ability to manipulate Nano-granular Tunnelling Resistive sensors

("NTR") on the sensor body for read-out of pressure variations. Lifecare's

sensor technology is referred to as "Sencell" and is suitable for identifying

and monitoring the occurrence of a wide range of analytes and molecules in the

human body.

Contacts

For further information, please contact:

Joacim Holter, CEO, Lifecare AS, [email protected], +47 40 05 90 40

Asle Wingsternes, Head of Communications & Public Affairs,

[email protected], +47 41 61 42 52